Caladrius Biosciences, Inc. – Product Pipeline Review

Global Markets Direct’s, ‘Caladrius Biosciences, Inc. – Product Pipeline Review – 2016’, provides an overview of the Caladrius Biosciences, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Caladrius Biosciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Caladrius Biosciences, Inc.

The report provides overview of Caladrius Biosciences, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Caladrius Biosciences, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Caladrius Biosciences, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Caladrius Biosciences, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Caladrius Biosciences, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Caladrius Biosciences, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Caladrius Biosciences, Inc. Snapshot 4

Caladrius Biosciences, Inc. Overview 4

Key Information 4

Key Facts 4

Caladrius Biosciences, Inc. - Research and Development Overview 5

Key Therapeutic Areas 5

Caladrius Biosciences, Inc. - Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products - Monotherapy 8

Pipeline Products - Partnered Products 9

Partnered Products/Combination Treatment Modalities 10

Caladrius Biosciences, Inc. - Pipeline Products Glance 11

Caladrius Biosciences, Inc. - Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Phase I Products/Combination Treatment Modalities 12

Caladrius Biosciences, Inc. - Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Discovery Products/Combination Treatment Modalities 14

Caladrius Biosciences, Inc. - Drug Profiles 15

CLBS-03 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

CLBS-12 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Stem Cell Therapy for AMD and Retinitis Pigmentosa 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Caladrius Biosciences, Inc. - Pipeline Analysis 19

Caladrius Biosciences, Inc. - Pipeline Products by Route of Administration 19

Caladrius Biosciences, Inc. - Pipeline Products by Molecule Type 20

Caladrius Biosciences, Inc. - Recent Pipeline Updates 21

Caladrius Biosciences, Inc. - Dormant Projects 24

Caladrius Biosciences, Inc. - Discontinued Pipeline Products 25

Discontinued Pipeline Product Profiles 25

CLBS-10 25

Caladrius Biosciences, Inc. - Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

List of Tables

List of Tables

Caladrius Biosciences, Inc. , Key Information 4

Caladrius Biosciences, Inc. , Key Facts 4

Caladrius Biosciences, Inc. – Pipeline by Indication, 2016 6

Caladrius Biosciences, Inc. – Pipeline by Stage of Development, 2016 7

Caladrius Biosciences, Inc. – Monotherapy Products in Pipeline, 2016 8

Caladrius Biosciences, Inc. – Partnered Products in Pipeline, 2016 9

Caladrius Biosciences, Inc. – Partnered Products/ Combination Treatment Modalities, 2016 10

Caladrius Biosciences, Inc. – Phase II, 2016 11

Caladrius Biosciences, Inc. – Phase I, 2016 12

Caladrius Biosciences, Inc. – Preclinical, 2016 13

Caladrius Biosciences, Inc. – Discovery, 2016 14

Caladrius Biosciences, Inc. – Pipeline by Route of Administration, 2016 19

Caladrius Biosciences, Inc. – Pipeline by Molecule Type, 2016 20

Caladrius Biosciences, Inc. – Recent Pipeline Updates, 2016 21

Caladrius Biosciences, Inc. – Dormant Developmental Projects,2016 24

Caladrius Biosciences, Inc. – Discontinued Pipeline Products, 2016 25

Caladrius Biosciences, Inc. , Other Locations 26

Caladrius Biosciences, Inc. , Subsidiaries 27

List of Figures

List of Figures

Caladrius Biosciences, Inc. – Pipeline by Indication, 2016 6

Caladrius Biosciences, Inc. – Pipeline by Stage of Development, 2016 7

Caladrius Biosciences, Inc. – Monotherapy Products in Pipeline, 2016 8

Caladrius Biosciences, Inc. – Pipeline by Route of Administration, 2016 19

Caladrius Biosciences, Inc. – Pipeline by Molecule Type, 2016 20

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports